SALAZOPYRINE Side Effects

7009598-0 | Febrile Neutropenia, Leukopenia
on Sep 13, 2010 Female patient from FRANCE , 58 years of age, was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, leukopenia. Salazopyrine dosage: Unk. During the same period patient was treated with VOLTAREN (Unk) (View Voltaren Review and Voltaren Label ).

7002712-2 | Mixed Liver Injury
Patient was taking Salazopyrine (View Usage). Patient had the following side effects: mixed liver injury on Sep 08, 2010 from FRANCE Additional patient health information: Male patient , 81 years of age, . Salazopyrine dosage: 2 Daily Doses (tablets). During the same period patient was treated with AUGMENTIN '125' (3 Df, 1x/day) (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

6938377-5 | Lymphadenopathy, Pyrexia, Rash Maculo-papular
Adverse event was reported on Aug 16, 2010 by a Female patient taking Salazopyrine (View Usage) (Dosage: Unk, 1x/day) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , 39 years of age, After Salazopyrine was administered, patient had the following side effects: lymphadenopathy, pyrexia, rash maculo-papular. During the same period patient was treated with VOLTAREN (1 Df, 1x/day) (View Voltaren Review and Voltaren Label ), ACUPAN (Unk) (View Acupan Review and Acupan Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), RIFAMATE (Unk) (View Rifamate Review and Rifamate Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), KLIPAL (View Klipal Review and Klipal Label ). Patient was hospitalized.

6928507-3 | Leukocytosis
on Aug 05, 2010 Female patient from FRANCE , 82 years of age, was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytosis. Salazopyrine dosage: Unk. Patient was hospitalized.


6917784-0 | Erythema, Hyperthermia
on Jul 29, 2010 Female patient from FRANCE , 50 years of age, was treated with Salazopyrine (View Usage). Patient had the following side effects: erythema, hyperthermia. Salazopyrine dosage: 500 Mg, 3x/day. Patient was hospitalized.

6917772-4 | Pancytopenia
Patient was taking Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: pancytopenia on Jul 29, 2010 from FRANCE Additional patient health information: Male patient , 61 years of age, . Salazopyrine dosage: 500 Mg, 6x/day. During the same period patient was treated with METOJECT (20 Mg, Monthly) (View Metoject Review and Metoject Label ), SKENAN (30 Mg, 2x/day) (View Skenan Review and Skenan Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), PARACETAMOL (1 G, 4x/day) (View Paracetamol Review and Paracetamol Label ), SPECIAFOLDINE (2 Daily Doses) (View Speciafoldine Review and Speciafoldine Label ), OMEPRAZOLE (20 Mg Per Day) (View Omeprazole Review and Omeprazole Label ), LOVENOX (0.4 Ml, 1x/day) (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6382175-0 | Dyspnoea, Haemoptysis, Interstitial Lung Disease
Adverse event was reported on Sep 16, 2009 by a Female patient taking Salazopyrine (View Usage) (Dosage: 1.5 G, 1x/day) was diagnosed with arthritis reactive and. Location: FRANCE , 87 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, haemoptysis, interstitial lung disease. During the same period patient was treated with KARDEGIC (75 Mg, Powder) (View Kardegic Review and Kardegic Label ), SOTALEX (80 Mg, Scored Tablet) (View Sotalex Review and Sotalex Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), PERMIXON (160 Mg Capsule) (View Permixon Review and Permixon Label ), SPASFON (Unk, Scored Tablet) (View Spasfon Review and Spasfon Label ), IPERTEN (View Iperten Review and Iperten Label ). Patient was hospitalized.

6246612-4 | Osteonecrosis
on Jun 16, 2009 Female patient from FRANCE , 48 years of age, was diagnosed with colitis and was treated with Salazopyrine (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Salazopyrine dosage: 500 Mg, 2x/day. During the same period patient was treated with IMUREL (Frequency: Every Day) (View Imurel Review and Imurel Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), NEORAL (Unk) (View Neoral Review and Neoral Label ), CORTANCYL (70 Mg, 1x/day) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6231983-5 | Angioedema, Asthma, Diplopia, Eye Pain, Headache, Migraine, Strabismus, Uterine Haemorrhage
on Jun 04, 2009 Female patient from FRANCE , 46 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), pain (What is pain?) and was treated with Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: angioedema, asthma (What is asthma?), diplopia, eye pain, headache (What is headache?), migraine (What is migraine?), strabismus, uterine haemorrhage. Salazopyrine dosage: . During the same period patient was treated with SOLUPRED (View Solupred Review and Solupred Label ), AERIUS (View Aerius Review and Aerius Label ), CELESTAMINE (View Celestamine Review and Celestamine Label ).

5971409-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Leukopenia, Lymphadenopathy, Lymphopenia, Platelet Count Decreased, Pyrexia
Patient was taking Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, leukopenia, lymphadenopathy, lymphopenia, platelet count decreased, pyrexia on Nov 20, 2008 from FRANCE Additional patient health information: Female patient , weighting 136.7 lb, was diagnosed with polyarthritis and. Salazopyrine dosage: .

5960699-5 | Renal Failure Acute
Adverse event was reported on Nov 17, 2008 by a Female patient taking Salazopyrine (View Usage) (Dosage: ) was diagnosed with arthralgia, prophylaxis and. Location: FRANCE , 77 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), ACECLOFENAC (View Aceclofenac Review and Aceclofenac Label ). Patient was hospitalized.

5922966-0 | Agranulocytosis, Pyrexia, Skin Reaction
on Oct 09, 2008 Female patient from FRANCE , 61 years of age, weighting 136.7 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: agranulocytosis, pyrexia, skin reaction. Salazopyrine dosage: . Patient was hospitalized.

5807928-6 | Leukopenia, Neutropenia
on Jun 30, 2008 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), hypercholesterolaemia, hypertension and was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia. Salazopyrine dosage: . During the same period patient was treated with MABTHERA (Daily Dose:1gram) (View Mabthera Review and Mabthera Label ), ARAVA (View Arava Review and Arava Label ), DOLIPRANE (Text:500) (View Doliprane Review and Doliprane Label ), ACTONEL (View Actonel Review and Actonel Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), LASIX (View Lasix Review and Lasix Label ).

5757596-7 | Renal Failure Acute
Patient was taking Salazopyrine (View Usage). Patient had the following side effects: renal failure acute on May 22, 2008 from FRANCE Additional patient health information: Female patient , 77 years of age, was diagnosed with arthralgia, prophylaxis and. Salazopyrine dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACECLOFENAC (View Aceclofenac Review and Aceclofenac Label ). Patient was hospitalized.

5741009-5 | Deafness Neurosensory, Neuritis
Adverse event was reported on May 05, 2008 by a Female patient taking Salazopyrine (View Usage) (Dosage: ) was diagnosed with arthritis (What is arthritis?) and. Location: FRANCE , 24 years of age, After Salazopyrine was administered, patient had the following side effects: deafness neurosensory, neuritis. During the same period patient was treated with BREXIN (View Brexin Review and Brexin Label ). Patient was hospitalized.

5613001-2 | Lichenification
on Jan 25, 2008 Male patient from FRANCE , weighting 149.9 lb, was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: lichenification. Salazopyrine dosage: Text:4 Tablets Daily.

5590729-4 | Abdominal Pain, Diarrhoea, Salmonellosis
on Jan 09, 2008 Female patient from FRANCE , 34 years of age, was treated with Salazopyrine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, salmonellosis. Salazopyrine dosage: Daily Dose:2gram. During the same period patient was treated with ADALIMUMAB (View Adalimumab Review and Adalimumab Label ). Patient was hospitalized.

5588547-6 | No Adverse Event
Patient was taking Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: no adverse event on Jan 09, 2008 from FRANCE Additional patient health information: Female patient , 34 years of age, . Salazopyrine dosage: Daily Dose:2gram. During the same period patient was treated with ADALIMUMAB (View Adalimumab Review and Adalimumab Label ).

5570251-1 | Abdominal Pain, Diarrhoea, Salmonellosis
Adverse event was reported on Dec 11, 2007 by a Female patient taking Salazopyrine (View Usage) (Dosage: Daily Dose:2gram) . Location: FRANCE , 34 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, salmonellosis. During the same period patient was treated with ADALIMUMAB (View Adalimumab Review and Adalimumab Label ). Patient was hospitalized.

5567620-2 | Abdominal Pain, Diarrhoea, Salmonellosis
on Dec 11, 2007 Female patient from FRANCE , 34 years of age, was treated with Salazopyrine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, salmonellosis. Salazopyrine dosage: Daily Dose:2gram. During the same period patient was treated with ADALIMUMAB (View Adalimumab Review and Adalimumab Label ). Patient was hospitalized.

5524224-5 | Axonal Neuropathy
on Sep 07, 2007 Male patient from FRANCE , weighting 154.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hyperuricaemia and was treated with Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: axonal neuropathy. Salazopyrine dosage: Text:6 Tablets. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ).

5491174-2 | Encephalopathy
Patient was taking Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy on Oct 08, 2007 from FRANCE Additional patient health information: Male patient , 38 years of age, was diagnosed with spondylitis and. Salazopyrine dosage: . Patient was hospitalized.

5425548-2 | Extrasystoles
Adverse event was reported on Aug 13, 2007 by a Female patient taking Salazopyrine (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , weighting 145.5 lb, Patient had the following side effects: extrasystoles. During the same period patient was treated with SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), TELFAST (View Telfast Review and Telfast Label ).

5408855-9 | Extrasystoles
on Jul 27, 2007 Female patient from FRANCE , 58 years of age, was treated with Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: extrasystoles. Salazopyrine dosage: .

5406544-8 | Abdominal Pain, Abdominal Pain Upper
on Jul 25, 2007 Female patient from BELGIUM , 67 years of age, was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal pain upper. Salazopyrine dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ).

5388546-3 | Headache, Meningitis, Myalgia, Photophobia, Pyrexia
Patient was taking Salazopyrine (View Usage). Patient had the following side effects: headache (What is headache?), meningitis (What is meningitis?), myalgia, photophobia, pyrexia on Jul 04, 2007 from FRANCE Additional patient health information: Female patient , 55 years of age, weighting 180.8 lb, was diagnosed with musculoskeletal pain, fibromyalgia, essential hypertension and. Salazopyrine dosage: . During the same period patient was treated with PRETERAX (View Preterax Review and Preterax Label ). Patient was hospitalized.

5382238-2 | Agranulocytosis, Sepsis
Adverse event was reported on Jun 27, 2007 by a Female patient taking Salazopyrine (View Usage) (Dosage: ) . Location: FRANCE , 84 years of age, After Salazopyrine was administered, patient had the following side effects: agranulocytosis, sepsis (What is sepsis?). During the same period patient was treated with ATHYMIL (View Athymil Review and Athymil Label ), CREON (View Creon Review and Creon Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NISISCO (View Nisisco Review and Nisisco Label ), PLAVIX (View Plavix Review and Plavix Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ACTONEL (View Actonel Review and Actonel Label ).

5380294-9 | Back Pain, Bence Jones Protein Urine Present, C-reactive Protein Increased, Depression, Electric Shock, Gamma-glutamyltransferase Increased, Haemorrhage, Libido Decreased, Liver Disorder
on Jun 07, 2007 Female patient from FRANCE , weighting 165.3 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), bence jones protein urine present, c-reactive protein increased, depression (What is depression?), electric shock, gamma-glutamyltransferase increased, haemorrhage, libido decreased, liver disorder. Salazopyrine dosage: . Patient was hospitalized and became disabled.

5377608-2 | Congenital Genitourinary Abnormality, Feeding Disorder Neonatal, Hyperbilirubinaemia Neonatal, Jaundice Neonatal, Nausea, Pregnancy, Pyelocaliectasis, Renal Dysplasia
on Jun 26, 2007 Male patient from FRANCE , weighting 14.77 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Salazopyrine (View Usage). Patient had the following side effects: congenital genitourinary abnormality, feeding disorder neonatal, hyperbilirubinaemia neonatal, jaundice neonatal, nausea (What is nausea?), pregnancy (What is pregnancy?), pyelocaliectasis, renal dysplasia. Salazopyrine dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), OGAST (View Ogast Review and Ogast Label ). Patient was hospitalized.

5375568-1 | Neuropathy Peripheral, Oedema Peripheral, Paraesthesia, Vascular Calcification
Patient was taking Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: neuropathy peripheral, oedema peripheral, paraesthesia, vascular calcification on Jun 18, 2007 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and. Salazopyrine dosage: Daily Dose:2gram-text:every Day. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), INSULIN (View Insulin Review and Insulin Label ).

5331581-1 | Headache, Meningitis, Myalgia, Photophobia, Pyrexia
Adverse event was reported on May 14, 2007 by a Female patient taking Salazopyrine (View Usage) (Dosage: ) was diagnosed with musculoskeletal pain, fibromyalgia, essential hypertension and. Location: FRANCE , 55 years of age, weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), meningitis (What is meningitis?), myalgia, photophobia, pyrexia. During the same period patient was treated with PRETERAX (View Preterax Review and Preterax Label ). Patient was hospitalized.

5315891-X | Headache, Meningitis, Myalgia, Photophobia, Pyrexia
on Apr 23, 2007 Female patient from FRANCE , 55 years of age, weighting 180.8 lb, was diagnosed with musculoskeletal pain, fibromyalgia, essential hypertension and was treated with Salazopyrine (View Usage). Patient had the following side effects: headache (What is headache?), meningitis (What is meningitis?), myalgia, photophobia, pyrexia. Salazopyrine dosage: . During the same period patient was treated with PRETERAX (View Preterax Review and Preterax Label ). Patient was hospitalized.

5314018-8 | Hepatic Enzyme Increased, Hyperventilation, Lymphadenopathy, Pyrexia, Rash Maculo-papular, Toxic Skin Eruption, Weight Decreased
on Apr 19, 2007 Female patient from FRANCE , 26 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?), hypothyroidism, bone pain and was treated with Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: hepatic enzyme increased, hyperventilation, lymphadenopathy, pyrexia, rash maculo-papular, toxic skin eruption, weight decreased. Salazopyrine dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), CAFFEINE/OPIUM/PARACETAMOL (View Caffeine/opium/paracetamol Review and Caffeine/opium/paracetamol Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ), PRISTINAMYCIN (View Pristinamycin Review and Pristinamycin Label ). Patient was hospitalized.

5313107-1 | Back Pain, C-reactive Protein Increased, Depression, Haemorrhage, Libido Decreased, Neuropathy Peripheral, Platelet Count Decreased, Proteinuria, Pyrexia
Patient was taking Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), c-reactive protein increased, depression (What is depression?), haemorrhage, libido decreased, neuropathy peripheral, platelet count decreased, proteinuria, pyrexia on Apr 19, 2007 from FRANCE Additional patient health information: Female patient , 61 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Salazopyrine dosage: . Patient was hospitalized.

5303612-6 | Hepatic Enzyme Increased, Hyperventilation, Lymphadenopathy, Pyrexia, Rash Maculo-papular, Toxic Skin Eruption, Weight Decreased
Adverse event was reported on Apr 12, 2007 by a Female patient taking Salazopyrine (View Usage) (Dosage: ) was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?), hypothyroidism, bone pain and. Location: FRANCE , 26 years of age, Patient had the following side effects: hepatic enzyme increased, hyperventilation, lymphadenopathy, pyrexia, rash maculo-papular, toxic skin eruption, weight decreased. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), CAFFEINE/OPIUM/PARACETAMOL (View Caffeine/opium/paracetamol Review and Caffeine/opium/paracetamol Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ). Patient was hospitalized.

5299965-8 | Hepatic Enzyme Increased, Hyperventilation, Lymphadenopathy, Pyrexia, Rash Maculo-papular, Toxic Skin Eruption, Weight Decreased
on Apr 09, 2007 Female patient from FRANCE , 26 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?), hypothyroidism, bone pain and was treated with Salazopyrine (View Usage). After Salazopyrine was administered, patient had the following side effects: hepatic enzyme increased, hyperventilation, lymphadenopathy, pyrexia, rash maculo-papular, toxic skin eruption, weight decreased. Salazopyrine dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), CAFFEINE/OPIUM/PARACETAMOL (View Caffeine/opium/paracetamol Review and Caffeine/opium/paracetamol Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ). Patient was hospitalized.

5290889-9 | Hepatic Enzyme Increased, Hyperventilation, Lymphadenopathy, Pyrexia, Rash Maculo-papular
on Mar 26, 2007 Female patient from FRANCE , 26 years of age, was diagnosed with hypothyroidism, bone pain and was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, hyperventilation, lymphadenopathy, pyrexia, rash maculo-papular. Salazopyrine dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), CAFFEINE/OPIUM/PARACETAMOL (View Caffeine/opium/paracetamol Review and Caffeine/opium/paracetamol Label ), TETRAZEPAM (View Tetrazepam Review and Tetrazepam Label ). Patient was hospitalized.

5280849-6 | Agranulocytosis, Cellulitis, Hypersensitivity, Pyrexia
Patient was taking Salazopyrine (View Usage). Patient had the following side effects: agranulocytosis, cellulitis (What is cellulitis?), hypersensitivity, pyrexia on Mar 19, 2007 from FRANCE Additional patient health information: Male patient , weighting 134.5 lb, was diagnosed with enterocolitis haemorrhagic and. Salazopyrine dosage: Freq:daily. During the same period patient was treated with AMINOSALICYLATE SODIUM (View Aminosalicylate Sodium Review and Aminosalicylate Sodium Label ), ROWASA (View Rowasa Review and Rowasa Label ).

5279529-2 | Hyperhidrosis, Polydipsia, Polyuria, Thirst
Adverse event was reported on Mar 16, 2007 by a Female patient taking Salazopyrine (View Usage) (Dosage: Daily Dose:1000mg) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: FRANCE , weighting 117.9 lb, After Salazopyrine was administered, patient had the following side effects: hyperhidrosis, polydipsia, polyuria, thirst. During the same period patient was treated with ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ).

5269226-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Pyrexia, Rash, Reticuloendothelial System Stimulated, Thrombocytopenia
on Mar 07, 2007 Female patient from FRANCE , 55 years of age, was diagnosed with musculoskeletal pain, arthritis (What is arthritis?) and was treated with Salazopyrine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, pyrexia, rash (What is rash?), reticuloendothelial system stimulated, thrombocytopenia. Salazopyrine dosage: . Patient was hospitalized.